Skip to main content
. 2015 Jul 27;112(33):10443–10448. doi: 10.1073/pnas.1513341112

Fig. S6.

Fig. S6.

Induction of U-ISGF3 after treatment of IFN-β and IFN-λ1 in PHHs, differentiated HepaRG cells, and HepG2 cells. PHHs, differentiated HepaRG cells, and HepG2 cells were treated with 1 ng/mL IFN-β or 100 ng/mL IFN-λ1 and harvested at the indicated time points. Immunoblotting of STAT1, PY-STAT1, STAT2, PY-STAT2, and IRF9 was performed.

HHS Vulnerability Disclosure